Skip to Main Content

Author Details

Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
1997
153
34
PMIDPaper TitleJournal TitlePublished Year
37548822Oncological outcomes after attempted nerve-sparing radical prostatectomy (NSRP) in patients with high-risk prostate cancer are comparable to standard non-NSRP: a longitudinal long-term propensity-matched single-centre study.BJU Int2024
36602577Investigating PSMA-PET/CT to resolve prostate MRI PIRADS4-5 and negative biopsy discordance.World J Urol2023
36610996A polygenic two-hit hypothesis for prostate cancer.J Natl Cancer Inst2023
36637213Same day discharge for robot-assisted radical prostatectomy: a prospective cohort study documenting an Australian approach.ANZ J Surg2023
34480323A review of simulation training and new 3D computer-generated synthetic organs for robotic surgery education.J Robot Surg2022
35435276Molecular classification of hormone-sensitive and castration-resistant prostate cancer, using nonnegative matrix factorization molecular subtyping of primary and metastatic specimens.Prostate2022
35688680Phase 2 Study of Neoadjuvant FGFR Inhibition and Androgen Deprivation Therapy Prior to Prostatectomy.Clin Genitourin Cancer2022
35659150Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study.Eur Urol2022
35813255Defining Prostatic Vascular Pedicle Recurrence and the Anatomy of Local Recurrence of Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography.Eur Urol Open Sci2022
35811101Identification and isolation of slow-cycling glioma stem cells.Methods Cell Biol2022
35713272A Historical Perspective of the Evolution of Laparoscopic Surgeries in Urology.J Endourol2022
36944050Representativeness of antihypertensive trials: analysis of serious adverse events.Ann Fam Med2022
36103484Perish and publish: Dynamics of biomedical publications by deceased authors.PLoS One2022
36306156Role for a Web-Based Intervention to Alleviate Distress in People With Newly Diagnosed Testicular Cancer: Mixed Methods Study.JMIR Cancer2022
36132374Long-term conditions, multimorbidity and colorectal cancer risk in the UK Biobank cohort.J Multimorb Comorb2022
36267199Active involvement of nursing staff in reporting and grading complication-intervention events-Protocol and results of the CAMUS Pilot Nurse Delphi Study.BJUI Compass2022
36230886Molecular Mechanisms Driving the Formation of Brain Metastases.Cancers (Basel)2022
36123093PEDAL protocol: a prospective single-arm paired comparison of multiparametric MRI and 18F-DCPFyl PSMA PET/CT to diagnose prostate cancer.BMJ Open2022
35879832Active surveillance versus enzalutamide for low-risk prostate cancer - was it really a trial we needed?BJU Int2022
35221259Protocol for CAMUS Delphi Study: A Consensus on Comprehensive Reporting and Grading of Complications After Urological Surgery.Eur Urol Focus2022
34993496Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.HGG Adv2022
34108644MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancer.Prostate Cancer Prostatic Dis2021
35475136Surgical innovation revisited: A historical narrative of the minimally invasive "Agarwal sliding-clip renorrhaphy" technique for partial nephrectomy and its application to an Australian cohort.BJUI Compass2021
35474704The utility of magnetic resonance imaging in prostate cancer diagnosis in the Australian setting.BJUI Compass2021
35474657Ductal adenocarcinoma of the prostate: A systematic review and meta-analysis of incidence, presentation, prognosis, and management.BJUI Compass2021
33824159The readability of general practice websites: a cross-sectional analysis of all general practice websites in Scotland.Br J Gen Pract2021
33678516Ductal variant prostate carcinoma is associated with a significantly shorter metastasis-free survival.Eur J Cancer2021
33541309A modified Delphi study to develop a practical guide for selecting patients with prostate cancer for active surveillance.BMC Urol2021
35008330Biomarkers of Response to Neoadjuvant Androgen Deprivation in Localised Prostate Cancer.Cancers (Basel)2021
34838271Lifetime Health and Economic Outcomes of Active Surveillance, Radical Prostatectomy, and Radiotherapy for Favorable-Risk Localized Prostate Cancer.Value Health2021
34322653Loss of <i>SNAI2</i> in Prostate Cancer Correlates With Clinical Response to Androgen Deprivation Therapy.JCO Precis Oncol2021
34294073Transcriptome sequencing and multi-plex imaging of prostate cancer microenvironment reveals a dominant role for monocytic cells in progression.BMC Cancer2021
34240062Observed and expected serious adverse event rates in randomised clinical trials for hypertension: an observational study comparing trials that do and do not focus on older people.Lancet Healthy Longev2021
34337517Health Economic Evidence for Liquid- and Tissue-based Molecular Tests that Inform Decisions on Prostate Biopsies and Treatment of Localised Prostate Cancer: A Systematic Review.Eur Urol Open Sci2021
34310033The modified International Society of Urological Pathology system improves concordance between biopsy and prostatectomy tumour grade.BJU Int2021
32314873Prostate cancer cell-intrinsic interferon signaling regulates dormancy and metastatic outgrowth in bone.EMBO Rep2020
33313578Frailty measurement, prevalence, incidence, and clinical implications in people with diabetes: a systematic review and study-level meta-analysis.Lancet Healthy Longev2020
32579772Use of prostate-specific membrane antigen positron-emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer.BJU Int2020
32807235Detection of ctDNA in plasma of patients with clinically localised prostate cancer is associated with rapid disease progression.Genome Med2020
32873673Identification and prevalence of frailty in diabetes mellitus and association with clinical outcomes: a systematic review protocol.BMJ Open2020
32392735The Impact of Whole Genome Data on Therapeutic Decision-Making in Metastatic Prostate Cancer: A Retrospective Analysis.Cancers (Basel)2020
32499442MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancer.Science2020
32233346Advances in prostate cancer.Aust J Gen Pract2020
30382379Developments in oligometastatic hormone-sensitive prostate cancer.World J Urol2019
30215171Supranutritional Sodium Selenate Supplementation Delivers Selenium to the Central Nervous System: Results from a Randomized Controlled Pilot Trial in Alzheimer's Disease.Neurotherapeutics2019
30248237Late biochemical recurrence after radical prostatectomy is associated with a slower rate of progression.BJU Int2019
30772200Prostatic nerve subtypes independently predict biochemical recurrence in prostate cancer.J Clin Neurosci2019
30886895Lessons Learned and New Challenges: Re-evaluation of End-User Assessment of a Skills-Based Training Program for Urology Trainees.J Med Educ Curric Dev2019
30959474Androgen deprivation therapy promotes an obesity-like microenvironment in periprostatic fat.Endocr Connect2019
30553611Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer.Eur Urol2019
  • 1 - 50 of 153

Recommended Authors

Northwestern University Feinberg School of Medicine
Career Start Year 2013
Number of shared co-authors 7
IRCCS San Raffaele Scientific Institute, Italy Vita-Salute San Raffaele University
Career Start Year 2012
Number of shared co-authors 12
University of Michigan Medical School ann arbor
Career Start Year 2012
Number of shared co-authors 13
university of california san diego School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Columbia University Medical Center
Career Start Year 2010
Number of shared co-authors 1
University of Texas Health San Antonio
Career Start Year 2008
Number of shared co-authors 6
Vanderbilt University Medical Center
Career Start Year 2008
Number of shared co-authors 12
University of Alberta
Career Start Year 2007
Number of shared co-authors 2
University of California San Diego
Career Start Year 2005
Number of shared co-authors 4
University of Washington Medical Center
Career Start Year 2005
Number of shared co-authors 14
Universitatsklinikum Hamburg-Eppendorf
Career Start Year 2004
Number of shared co-authors 21
Northwestern University
Career Start Year 2003
Number of shared co-authors 19
University Hospital Southampton NHS Foundation Trust
Career Start Year 2002
Number of shared co-authors 26
IRCCS San Raffaele Scientific Institute
Career Start Year 2002
Number of shared co-authors 25
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 26
Erasmus MC Cancer Institute, University Medical Center
Career Start Year 1998
Number of shared co-authors 11
Cedars-Sinai Medical Center
Career Start Year 1996
Number of shared co-authors 25
Radboud University Medical Center
Career Start Year 1995
Number of shared co-authors 17
CHU de Quebec-Universite Laval
Career Start Year 1994
Number of shared co-authors 18
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 13
University Health Network, Princess Margaret Cancer Center, University of Toronto
Career Start Year 1993
Number of shared co-authors 17
David Geffen School of Medicine at university of california los angeles
Career Start Year 1993
Number of shared co-authors 19
University Hospital Frankfurt, Goethe University Frankfurt am Main
Career Start Year 1993
Number of shared co-authors 23
Washington State University Elson S. Floyd College of Medicine
Career Start Year 1992
Number of shared co-authors 9
University of Montreal Health Center
Career Start Year 1990
Number of shared co-authors 22
Liverpool University Hospitals
Career Start Year 1988
Number of shared co-authors 6
Skane University Hospital, Lund University
Career Start Year 1987
Number of shared co-authors 25
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 15
Johns Hopkins University School of Medicine
Career Start Year 1984
Number of shared co-authors 13
University of Western Ontario
Career Start Year 1982
Number of shared co-authors 11

Collaborators

Royal Melbourne Hospital, The University of Melbourne
Co-authored papers 77
Royal Melbourne Hospital
Co-authored papers 74
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 12
Australian Prostate Cancer Research Centre Epworth
Co-authored papers 9
University of British Columbia
Co-authored papers 7
Peter MacCallum Cancer Centre, University of Melbourne
Co-authored papers 7
Monash University
Co-authored papers 5
University of Melbourne
Co-authored papers 4
Co-authored papers 4
University of California los angeles
Co-authored papers 4
University of Melbourne
Co-authored papers 4
University of Oxford, John Radcliffe Hospital
Co-authored papers 3
University of Oxford
Co-authored papers 3
University of Oxford
Co-authored papers 3
Manchester Cancer Research Centre, University of Manchester
Co-authored papers 3
Weill Medical College of Cornell University
Co-authored papers 3
University of Melbourne, The University of Melbourne
Co-authored papers 3
University of Copenhagen
Co-authored papers 2
NIHR Oxford Biomedical Research Centre
Co-authored papers 2
University of California san francisco
Co-authored papers 2
Ghent University, GZA Ziekenhuizen
Co-authored papers 2
the University of Melbourne
Co-authored papers 2
Cancer Health Services Research, The University of Melbourne
Co-authored papers 2
Cambridge University Hospitals National Health Service Foundation Trust
Co-authored papers 2
University of British Columbia
Co-authored papers 2
Technical Medical Centre, University of Twente
Co-authored papers 2
University of Cambridge
Co-authored papers 2
University of Toronto
Co-authored papers 2
The Francis Crick Institute
Co-authored papers 2
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2